The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/11717
StudyName: Eligibility Aliskiren and Valsartan Acute Coronary Syndrome NCT00409578
Date of export from the portal: 02.07.2020
Date of Upload / last change: 28.07.2015
License: Creative Commons BY 4.0

----

Description: 
The purpose of this study is to test the hypothesis that the inhibition of the renin-angiotensin-aldosterone system (RAAS) with the angiotensin receptor blocker valsartan or the renin antagonist aliskiren will improve ventricular hemodynamics, as reflected by a greater reduction in levels of N-terminal proB-type natriuretic peptide (NT-proBNP) compared to placebo in subjects stabilized following acute coronary syndrome (ACS) who are determined to be at high risk due to an elevated concentration of natriuretic peptides.
https://clinicaltrials.gov/ct2/show/NCT00409578
